Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy

99m Technetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate Cancer

(2018) Tobias Maurer et al.   EUROPEAN UROLOGY

Novel technology of molecular radio-guidance for lymph node dissection in recurrent prostate cancer by PSMA-ligands

(2018) Isabel Rauscher et al.   WORLD JOURNAL OF UROLOGY

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

(2017) Philip Cornford et al.   EUROPEAN UROLOGY

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

(2017) Nicolas Mottet et al.   EUROPEAN UROLOGY

Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients

(2017) Sebastian Zschaeck et al.   Radiation Oncology

Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer

(2017) Cordula A. Jilg et al.   Theranostics

111In- and IRDye800CW-Labeled PLA–PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues

(2016) Sangeeta R. Banerjee et al.   BIOMACROMOLECULES

Value of 111 In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up

(2016) Isabel Rauscher et al.   BJU INTERNATIONAL

68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer

(2016) Annika Herlemann et al.   EUROPEAN UROLOGY

Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

(2016) Tobias Maurer et al.   JOURNAL OF UROLOGY

More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer

(2015) Firas Abdollah et al.   EUROPEAN UROLOGY

Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer

(2015) Tobias Maurer et al.   EUROPEAN UROLOGY

Contemporary Role of Salvage Lymphadenectomy in Patients with Recurrence Following Radical Prostatectomy

(2015) Firas Abdollah et al.   EUROPEAN UROLOGY

Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

(2015) M. Eiber et al.   JOURNAL OF NUCLEAR MEDICINE

(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors

(2015) Eleni Gourni et al.   PLoS One

Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

(2013) Ali Afshar-Oromieh et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer

(2013) S. M. Hillier et al.   JOURNAL OF NUCLEAR MEDICINE